Little is known about the molecular mechanism of Schiff base hydrolysis in rhodopsin. We report here our investigation into this process focusing on the role of amino acids involved in a hydrogen bond network around the retinal Schiff base. We find conservative mutations in this network (T94I, E113Q, S186A, E181Q, Y192F, and Y268F) increase the activation energy (E a ) and abolish the concave Arrhenius plot normally seen for Schiff base hydrolysis in dark state rhodopsin. Interestingly, two mutants (T94I and E113Q) show dramatically faster rates of Schiff base hydrolysis in dark state rhodopsin, yet slower hydrolysis rates in the active MII form. We find deuterium affects the hydrolysis process in wild-type rhodopsin, exhibiting a specific isotope effect of ϳ2.5, and proton inventory studies indicate that multiple proton transfer events occur during the process of Schiff base hydrolysis for both dark state and MII forms. Taken together, our study demonstrates the importance of the retinal hydrogen bond network both in maintaining Schiff base integrity in dark state rhodopsin, as well as in catalyzing the hydrolysis and release of retinal from the MII form. Finally, we note that the dramatic alteration of Schiff base stability caused by mutation T94I may play a causative role in congenital night blindness as has been suggested by the Oprian and Garriga laboratories.Rhodopsin, the dim light photoreceptor of rod cells, is arguably the best characterized member of the class A superfamily of GPCR (1-7). A transmembrane receptor, it has evolved into an efficient photoreceptor by covalently binding its chromophore, 11-cis-retinal, to lysine 296 via a protonated Schiff base linkage within the helical bundle (8, 9). Dim light vision begins when the 11-cis-retinal chromophore absorbs a photon and isomerizes to the all-trans-retinal form. This change in retinal initiates a series of photo-intermediates and conformational changes in the protein, resulting in the formation of metarhodopsin II (MII), 1 the active conformation of rhodopsin that is able to bind and activate the G-protein transducin. The MII photoproduct is in dynamic equilibrium with its predecessor MI, and this MI/MII pool is thought to decay through two processes (10). The MII product may be directly hydrolyzed and release all-trans-retinal from the binding pocket, or the MI pool may undergo an addition thermal isomerization along the chromophore CϭN double bond (all-trans 15-syn) giving rise to the MIII storage product (10). This MIII intermediate also decays to opsin and all-trans-retinal (albeit at a slower rate) either through the MI/MII pool or possibly direct retinal Schiff base hydrolysis of the MIII intermediate. Rhodopsin deactivation ultimately requires hydrolysis of the all-trans-retinal Schiff base linkage and release of retinal from the binding pocket. Recycling the receptor and returning it to a photosensitive conformational state completes the recovery process (11). The retinoid cycle accomplishes this task by converting the released all-trans-...